Addiction Research

According to the World Health Organization (WHO), addiction is 'a chronic disease of the central nervous system that is characterized by a loss of control over impulsive behavior that leads to compulsive drug seeking and taking, and to relapses even after months of abstinence'. Addiction is a complex neuroadaptive process, where drugs of abuse alter cellular and molecular aspects of neural function. The brain circuits mediating the various behavioral effects of these drugs are rendered more, or less, responsive to those effects.

Addiction Research Products Targets

Products for Addiction Research - Page 36

Cat.No. Product Name Information/Activity
BCC5883 PDZ1 Domain inhibitor peptide 1315378-73-4
BCC7995 2-MPPA 254737-29-6
BCC6634 N-Acetylglycyl-D-glutamic acid 135701-69-8
BCC6612 L-AP6 78944-89-5
BCC7400 L-BMAA hydrochloride 16012-55-8
BCC6585 2,4-Dihydroxyphenylacetyl-L-asparagine 111872-98-1
BCC5051 Lamotrigine Lamotrigine(BW430C) is a novel anticonvulsant drug for inhibition of 5-HT and sodium channel Target: Sodium Channel Lamotrigine stabilises presynaptic neuronal membranes by blockade of voltage-dependent sodium channels, thus preventing the release of excitatory neurotransmitters, particularly glutamate and aspartate [1].
BCC7086 MNI-caged-L-glutamate 295325-62-1
BCC7453 Pentylenetetrazole 54-95-5
BCC6731 Salsolinol-1-carboxylic acid 57256-34-5